Search results
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 15 hours agoWhile Novavax's vaccine did finally reach the market in mid-2022 targeting the booster market, it...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 17 hours agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
Why Novavax Stock More Than Doubled Today
Motley Fool via Yahoo Finance· 18 hours agoThese results, however, took a back seat to news of the partnership with Sanofi. Besides the rights to sell Novavax's existing COVID vaccine, Sanofi will...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 1 day agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
NVAX Stock Alert: Novavax Just Hit a New 52-Week High
InvestorPlace· 18 hours agoNovavax (NASDAQ:NVAX) stock investors are celebrating on Friday as the vaccine company’s shares hit...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 21 hours agoFriday, Novavax Inc (NASDAQ: NVAX) entered a co-exclusive licensing agreement with Sanofi SA...
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
InvestorPlace· 19 hours agoNovavax (NASDAQ:NVAX) stock has more than doubled today and is up more than 120% at the time of this...
Novavax Shares Surge Over 130% After $1.4 Billion Covid Shot Deal With Sanofi
Forbes· 1 day agoShares for Novavax swelled by more than 130% Friday morning, after the biotech firm announced a $1.4...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 23 hours agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Novavax Stock More Than Doubles On Deal With Sanofi To Co-commercialize Covid-19 Vaccine
RTT News· 22 hours agoShares of American drug maker, Novavax, Inc. (NVAX), were surging in the pre-market trade on Friday after the company announced a narrower loss for the first-quarter and a ...